Ann Olincy
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 85 | 2022 | 544 | 7.310 |
Why?
| Evoked Potentials, Auditory | 24 | 2020 | 212 | 2.910 |
Why?
| Schizophrenic Psychology | 27 | 2019 | 119 | 2.310 |
Why?
| Nicotinic Agonists | 11 | 2017 | 110 | 2.010 |
Why?
| Psychotic Disorders | 9 | 2020 | 154 | 1.470 |
Why?
| Receptors, Nicotinic | 21 | 2017 | 309 | 1.470 |
Why?
| Endophenotypes | 14 | 2016 | 31 | 1.370 |
Why?
| Benzylidene Compounds | 8 | 2017 | 28 | 1.270 |
Why?
| Saccades | 16 | 2014 | 52 | 1.240 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 13 | 2017 | 120 | 1.210 |
Why?
| Pyridines | 8 | 2017 | 440 | 0.980 |
Why?
| Neuropsychological Tests | 19 | 2019 | 1072 | 0.930 |
Why?
| Sensory Gating | 5 | 2020 | 45 | 0.900 |
Why?
| Nicotine | 11 | 2017 | 276 | 0.870 |
Why?
| Bipolar Disorder | 5 | 2013 | 207 | 0.850 |
Why?
| Smoking | 9 | 2016 | 1556 | 0.850 |
Why?
| Genetic Predisposition to Disease | 24 | 2022 | 2359 | 0.780 |
Why?
| Pursuit, Smooth | 7 | 2010 | 23 | 0.720 |
Why?
| Neural Inhibition | 10 | 2010 | 165 | 0.680 |
Why?
| Brain | 18 | 2016 | 2540 | 0.660 |
Why?
| Genome-Wide Association Study | 9 | 2022 | 1376 | 0.610 |
Why?
| Schizotypal Personality Disorder | 2 | 2014 | 11 | 0.570 |
Why?
| Cognitive Dysfunction | 2 | 2019 | 309 | 0.540 |
Why?
| Acoustic Stimulation | 12 | 2020 | 333 | 0.500 |
Why?
| Adult | 63 | 2019 | 32385 | 0.480 |
Why?
| Attention | 10 | 2016 | 443 | 0.450 |
Why?
| Psychiatric Status Rating Scales | 13 | 2017 | 531 | 0.430 |
Why?
| Middle Aged | 46 | 2020 | 28563 | 0.420 |
Why?
| Family | 10 | 2016 | 595 | 0.420 |
Why?
| Attention Deficit Disorder with Hyperactivity | 6 | 2015 | 374 | 0.420 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 350 | 0.410 |
Why?
| Cognition Disorders | 7 | 2017 | 547 | 0.400 |
Why?
| Electroencephalography | 9 | 2020 | 408 | 0.390 |
Why?
| Male | 66 | 2020 | 59639 | 0.380 |
Why?
| Psychomotor Performance | 5 | 2016 | 307 | 0.370 |
Why?
| Reflex, Startle | 5 | 2012 | 67 | 0.370 |
Why?
| Memory, Short-Term | 5 | 2019 | 250 | 0.360 |
Why?
| DNA Copy Number Variations | 3 | 2016 | 167 | 0.360 |
Why?
| Chromosomes, Human, Pair 15 | 11 | 2012 | 74 | 0.340 |
Why?
| Cross-Over Studies | 8 | 2016 | 469 | 0.330 |
Why?
| Female | 64 | 2020 | 63629 | 0.330 |
Why?
| Humans | 94 | 2022 | 122796 | 0.320 |
Why?
| Polymorphism, Single Nucleotide | 11 | 2022 | 2127 | 0.320 |
Why?
| Evoked Potentials | 4 | 2020 | 124 | 0.320 |
Why?
| Deep Brain Stimulation | 2 | 2020 | 72 | 0.310 |
Why?
| Phenotype | 13 | 2016 | 3070 | 0.310 |
Why?
| Siblings | 6 | 2015 | 235 | 0.310 |
Why?
| Promoter Regions, Genetic | 4 | 2007 | 1188 | 0.280 |
Why?
| Nerve Net | 3 | 2019 | 249 | 0.260 |
Why?
| Genotype | 11 | 2016 | 1943 | 0.250 |
Why?
| Paternal Age | 2 | 2014 | 4 | 0.250 |
Why?
| Double-Blind Method | 6 | 2017 | 1711 | 0.240 |
Why?
| Auditory Perception | 5 | 2014 | 112 | 0.240 |
Why?
| Antipsychotic Agents | 3 | 2017 | 197 | 0.240 |
Why?
| Genetic Markers | 9 | 2016 | 358 | 0.240 |
Why?
| Eye Movements | 4 | 2010 | 58 | 0.230 |
Why?
| Hippocampus | 6 | 2015 | 747 | 0.220 |
Why?
| Verbal Learning | 3 | 2014 | 78 | 0.200 |
Why?
| Young Adult | 16 | 2017 | 11094 | 0.200 |
Why?
| Cognition | 4 | 2017 | 1066 | 0.200 |
Why?
| Essential Tremor | 1 | 2020 | 7 | 0.190 |
Why?
| Case-Control Studies | 11 | 2016 | 3296 | 0.180 |
Why?
| Genetic Association Studies | 2 | 2012 | 383 | 0.170 |
Why?
| Severity of Illness Index | 8 | 2015 | 2784 | 0.170 |
Why?
| Thalamus | 1 | 2020 | 83 | 0.170 |
Why?
| Bombesin | 1 | 1999 | 15 | 0.170 |
Why?
| Reference Values | 6 | 2010 | 789 | 0.170 |
Why?
| Corpus Striatum | 1 | 2020 | 130 | 0.170 |
Why?
| Adolescent | 21 | 2017 | 18948 | 0.170 |
Why?
| Genetic Linkage | 9 | 2012 | 328 | 0.160 |
Why?
| Epidemiologic Research Design | 2 | 2015 | 31 | 0.160 |
Why?
| Neurocognitive Disorders | 1 | 2017 | 25 | 0.150 |
Why?
| Allosteric Regulation | 1 | 2017 | 87 | 0.150 |
Why?
| Isoxazoles | 1 | 2017 | 56 | 0.150 |
Why?
| Reaction Time | 7 | 2020 | 416 | 0.150 |
Why?
| Anilides | 1 | 2017 | 69 | 0.150 |
Why?
| Birth Order | 1 | 2016 | 13 | 0.140 |
Why?
| Prepulse Inhibition | 1 | 2015 | 11 | 0.140 |
Why?
| Aged | 17 | 2020 | 20495 | 0.140 |
Why?
| Maternal Age | 1 | 2016 | 124 | 0.140 |
Why?
| Lod Score | 4 | 2013 | 76 | 0.140 |
Why?
| Neural Pathways | 3 | 2020 | 289 | 0.130 |
Why?
| Genetic Loci | 1 | 2016 | 296 | 0.130 |
Why?
| Brain Mapping | 6 | 2015 | 552 | 0.130 |
Why?
| Magnetic Resonance Imaging | 9 | 2019 | 3264 | 0.130 |
Why?
| Executive Function | 1 | 2019 | 406 | 0.130 |
Why?
| Linear Models | 2 | 2014 | 854 | 0.120 |
Why?
| Chromosome Mapping | 5 | 2008 | 518 | 0.120 |
Why?
| Brain Waves | 1 | 2013 | 25 | 0.120 |
Why?
| Sex Differentiation | 1 | 2013 | 13 | 0.110 |
Why?
| Autistic Disorder | 1 | 2015 | 176 | 0.110 |
Why?
| Multifactorial Inheritance | 2 | 2012 | 142 | 0.110 |
Why?
| Sensation Disorders | 1 | 2013 | 33 | 0.110 |
Why?
| Memory Disorders | 2 | 2013 | 170 | 0.110 |
Why?
| Alleles | 5 | 2022 | 852 | 0.110 |
Why?
| Inheritance Patterns | 2 | 2013 | 50 | 0.110 |
Why?
| Ocular Motility Disorders | 2 | 2004 | 27 | 0.110 |
Why?
| Analysis of Variance | 4 | 2015 | 1329 | 0.100 |
Why?
| ROC Curve | 2 | 2016 | 494 | 0.100 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2009 | 49 | 0.100 |
Why?
| Memory | 2 | 2007 | 242 | 0.100 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2011 | 51 | 0.100 |
Why?
| Chromosome Deletion | 1 | 2011 | 97 | 0.100 |
Why?
| Single-Blind Method | 3 | 2016 | 275 | 0.100 |
Why?
| Mental Recall | 3 | 2014 | 185 | 0.090 |
Why?
| Pedigree | 7 | 2007 | 492 | 0.090 |
Why?
| Image Processing, Computer-Assisted | 4 | 2019 | 739 | 0.090 |
Why?
| Placebos | 2 | 2006 | 204 | 0.080 |
Why?
| Genetic Variation | 4 | 2015 | 952 | 0.080 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 242 | 0.080 |
Why?
| Cerebellum | 1 | 2010 | 205 | 0.080 |
Why?
| Linkage Disequilibrium | 4 | 2012 | 279 | 0.080 |
Why?
| Polymorphism, Genetic | 3 | 2007 | 666 | 0.080 |
Why?
| Aging | 2 | 1999 | 1694 | 0.080 |
Why?
| Cerebral Cortex | 2 | 2010 | 430 | 0.080 |
Why?
| Age of Onset | 2 | 2007 | 479 | 0.080 |
Why?
| Haplotypes | 2 | 2008 | 482 | 0.080 |
Why?
| Drug Administration Schedule | 2 | 2008 | 757 | 0.080 |
Why?
| Logistic Models | 2 | 2016 | 1995 | 0.080 |
Why?
| Interview, Psychological | 1 | 2007 | 95 | 0.080 |
Why?
| Risk Factors | 6 | 2016 | 9381 | 0.080 |
Why?
| Arthritis, Rheumatoid | 1 | 2015 | 985 | 0.070 |
Why?
| Polymorphism, Single-Stranded Conformational | 2 | 2003 | 32 | 0.070 |
Why?
| Mental Processes | 1 | 2007 | 40 | 0.070 |
Why?
| Task Performance and Analysis | 1 | 2007 | 170 | 0.070 |
Why?
| Treatment Outcome | 3 | 2016 | 9692 | 0.070 |
Why?
| Psychology | 1 | 2007 | 85 | 0.070 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2006 | 34 | 0.070 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2006 | 67 | 0.070 |
Why?
| Ondansetron | 1 | 2005 | 11 | 0.070 |
Why?
| Electrooculography | 1 | 2005 | 11 | 0.070 |
Why?
| Serotonin Antagonists | 1 | 2005 | 31 | 0.070 |
Why?
| Mental Disorders | 1 | 2013 | 952 | 0.070 |
Why?
| Risk | 3 | 2016 | 890 | 0.060 |
Why?
| Orientation | 2 | 2006 | 46 | 0.060 |
Why?
| Cohort Studies | 4 | 2016 | 5294 | 0.060 |
Why?
| Learning | 2 | 2007 | 387 | 0.060 |
Why?
| Biomarkers | 3 | 2017 | 3662 | 0.060 |
Why?
| Personality Inventory | 1 | 2005 | 137 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 3 | 2010 | 1981 | 0.060 |
Why?
| Cooperative Behavior | 1 | 2006 | 410 | 0.060 |
Why?
| Gene Duplication | 1 | 2003 | 66 | 0.060 |
Why?
| Models, Genetic | 1 | 2006 | 599 | 0.060 |
Why?
| Genome, Human | 3 | 2013 | 392 | 0.060 |
Why?
| Perceptual Disorders | 1 | 2003 | 23 | 0.060 |
Why?
| Diagnosis, Differential | 1 | 2007 | 1423 | 0.060 |
Why?
| Animals | 6 | 2015 | 34133 | 0.060 |
Why?
| Factor Analysis, Statistical | 2 | 2015 | 283 | 0.060 |
Why?
| Sensitivity and Specificity | 1 | 2007 | 1855 | 0.060 |
Why?
| Sleep, REM | 1 | 2003 | 53 | 0.060 |
Why?
| Patient Selection | 1 | 2006 | 717 | 0.050 |
Why?
| Hearing Disorders | 1 | 2001 | 10 | 0.050 |
Why?
| Models, Neurological | 2 | 2000 | 228 | 0.050 |
Why?
| Arousal | 2 | 2015 | 164 | 0.050 |
Why?
| Acetylcholine | 1 | 2001 | 211 | 0.050 |
Why?
| Mice | 4 | 2015 | 15888 | 0.050 |
Why?
| Cocaine-Related Disorders | 1 | 2001 | 110 | 0.050 |
Why?
| Brain Injury, Chronic | 1 | 2000 | 25 | 0.050 |
Why?
| Nervous System | 1 | 2000 | 67 | 0.040 |
Why?
| Schizophrenia, Childhood | 1 | 1999 | 4 | 0.040 |
Why?
| Cholinergic Agents | 2 | 2015 | 18 | 0.040 |
Why?
| Gene Frequency | 3 | 2006 | 522 | 0.040 |
Why?
| Synaptic Transmission | 2 | 2017 | 240 | 0.040 |
Why?
| Family Health | 2 | 2014 | 201 | 0.040 |
Why?
| Microsatellite Repeats | 2 | 2012 | 147 | 0.040 |
Why?
| Archaeal Proteins | 1 | 2017 | 49 | 0.040 |
Why?
| Self Administration | 1 | 1997 | 125 | 0.040 |
Why?
| Genomics | 1 | 2022 | 714 | 0.040 |
Why?
| Delayed-Action Preparations | 1 | 2017 | 162 | 0.040 |
Why?
| Denmark | 1 | 2016 | 41 | 0.040 |
Why?
| Environment | 2 | 2008 | 357 | 0.030 |
Why?
| Psychometrics | 2 | 2011 | 672 | 0.030 |
Why?
| Oxygen | 2 | 2010 | 887 | 0.030 |
Why?
| Eye Movement Measurements | 1 | 2014 | 12 | 0.030 |
Why?
| Computers | 1 | 2015 | 66 | 0.030 |
Why?
| Cues | 1 | 1997 | 310 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 376 | 0.030 |
Why?
| Sex Distribution | 1 | 2015 | 370 | 0.030 |
Why?
| Administration, Cutaneous | 1 | 2014 | 126 | 0.030 |
Why?
| Memory, Episodic | 1 | 2015 | 44 | 0.030 |
Why?
| Receptors, Cholinergic | 2 | 2008 | 48 | 0.030 |
Why?
| Nuclear Family | 1 | 2014 | 55 | 0.030 |
Why?
| Gene-Environment Interaction | 1 | 2015 | 206 | 0.030 |
Why?
| Visual Perception | 1 | 2015 | 154 | 0.030 |
Why?
| Genetic Heterogeneity | 1 | 2013 | 56 | 0.030 |
Why?
| Child | 4 | 2015 | 19561 | 0.030 |
Why?
| California | 1 | 2014 | 387 | 0.030 |
Why?
| Speech Perception | 1 | 2014 | 92 | 0.030 |
Why?
| Peptides | 1 | 1999 | 893 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2013 | 256 | 0.030 |
Why?
| Symptom Assessment | 1 | 2014 | 124 | 0.030 |
Why?
| Child Development Disorders, Pervasive | 1 | 2013 | 65 | 0.030 |
Why?
| Disease Models, Animal | 3 | 2015 | 3799 | 0.030 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2013 | 72 | 0.030 |
Why?
| Predictive Value of Tests | 2 | 2013 | 1947 | 0.030 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 17 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 1531 | 0.030 |
Why?
| Genotyping Techniques | 1 | 2012 | 77 | 0.030 |
Why?
| Genetic Pleiotropy | 1 | 2011 | 30 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2011 | 73 | 0.020 |
Why?
| Age Factors | 2 | 2014 | 3114 | 0.020 |
Why?
| Sequence Analysis, DNA | 2 | 2003 | 766 | 0.020 |
Why?
| Depressive Disorder, Major | 1 | 2013 | 309 | 0.020 |
Why?
| Crohn Disease | 1 | 2013 | 200 | 0.020 |
Why?
| Sample Size | 1 | 2010 | 135 | 0.020 |
Why?
| Statistics as Topic | 1 | 2010 | 314 | 0.020 |
Why?
| Artifacts | 1 | 2010 | 130 | 0.020 |
Why?
| Odds Ratio | 1 | 2012 | 1043 | 0.020 |
Why?
| Major Histocompatibility Complex | 1 | 2009 | 224 | 0.020 |
Why?
| Brief Psychiatric Rating Scale | 1 | 2008 | 5 | 0.020 |
Why?
| Europe | 1 | 2009 | 369 | 0.020 |
Why?
| Serial Learning | 1 | 2008 | 9 | 0.020 |
Why?
| Catechol O-Methyltransferase | 1 | 2008 | 19 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2013 | 2079 | 0.020 |
Why?
| Quality Control | 1 | 2008 | 165 | 0.020 |
Why?
| Parents | 1 | 2015 | 1256 | 0.020 |
Why?
| Contingent Negative Variation | 1 | 2006 | 9 | 0.020 |
Why?
| Event-Related Potentials, P300 | 1 | 2006 | 18 | 0.020 |
Why?
| Twin Studies as Topic | 1 | 2006 | 19 | 0.020 |
Why?
| Discrimination Learning | 1 | 2006 | 53 | 0.020 |
Why?
| Color Perception | 1 | 2006 | 25 | 0.020 |
Why?
| Genetic Research | 1 | 2006 | 20 | 0.020 |
Why?
| Neurons | 1 | 2014 | 1345 | 0.020 |
Why?
| Rats | 1 | 2015 | 5426 | 0.020 |
Why?
| Binomial Distribution | 1 | 2006 | 6 | 0.020 |
Why?
| Dinucleotide Repeats | 1 | 2006 | 5 | 0.020 |
Why?
| Observer Variation | 1 | 2006 | 314 | 0.020 |
Why?
| Multicenter Studies as Topic | 1 | 2006 | 247 | 0.020 |
Why?
| Research Support as Topic | 1 | 2006 | 122 | 0.020 |
Why?
| Neuregulin-1 | 1 | 2006 | 43 | 0.020 |
Why?
| Quetiapine Fumarate | 1 | 2004 | 28 | 0.020 |
Why?
| Clozapine | 1 | 2004 | 21 | 0.020 |
Why?
| Dibenzothiazepines | 1 | 2004 | 20 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2006 | 416 | 0.020 |
Why?
| Risperidone | 1 | 2004 | 27 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2015 | 4734 | 0.020 |
Why?
| Follow-Up Studies | 2 | 2008 | 4768 | 0.020 |
Why?
| Consensus | 1 | 2007 | 554 | 0.020 |
Why?
| Pregnancy | 1 | 2016 | 5854 | 0.010 |
Why?
| Visual Fields | 1 | 2004 | 79 | 0.010 |
Why?
| Benzodiazepines | 1 | 2004 | 125 | 0.010 |
Why?
| United States | 3 | 2007 | 13272 | 0.010 |
Why?
| Early Diagnosis | 1 | 2005 | 242 | 0.010 |
Why?
| Data Collection | 1 | 2006 | 667 | 0.010 |
Why?
| Mutation | 1 | 2014 | 3493 | 0.010 |
Why?
| Head | 1 | 2004 | 95 | 0.010 |
Why?
| Auditory Perceptual Disorders | 1 | 2002 | 13 | 0.010 |
Why?
| Introns | 1 | 2003 | 236 | 0.010 |
Why?
| Prospective Studies | 1 | 2014 | 6704 | 0.010 |
Why?
| Exons | 1 | 2003 | 310 | 0.010 |
Why?
| Frontal Lobe | 1 | 2004 | 152 | 0.010 |
Why?
| Time Factors | 1 | 2013 | 6682 | 0.010 |
Why?
| gamma-Aminobutyric Acid | 1 | 2003 | 155 | 0.010 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2001 | 15 | 0.010 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2001 | 19 | 0.010 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2001 | 20 | 0.010 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2001 | 43 | 0.010 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2001 | 64 | 0.010 |
Why?
| Catecholamines | 1 | 2002 | 103 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2005 | 988 | 0.010 |
Why?
| Nerve Tissue Proteins | 1 | 2006 | 557 | 0.010 |
Why?
| Movement | 1 | 2004 | 257 | 0.010 |
Why?
| DNA Mutational Analysis | 1 | 2002 | 390 | 0.010 |
Why?
| Hallucinations | 1 | 2001 | 31 | 0.010 |
Why?
| Lymphocytes | 1 | 2002 | 360 | 0.010 |
Why?
| Psychophysics | 1 | 1999 | 19 | 0.010 |
Why?
| Base Sequence | 1 | 2003 | 2186 | 0.010 |
Why?
| Pattern Recognition, Visual | 1 | 2000 | 106 | 0.010 |
Why?
| Chromosome Disorders | 1 | 1999 | 40 | 0.010 |
Why?
| Fathers | 1 | 1999 | 47 | 0.010 |
Why?
| Cocaine | 1 | 2001 | 157 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2000 | 551 | 0.010 |
Why?
| Chromosome Aberrations | 1 | 1999 | 136 | 0.010 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2000 | 146 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2003 | 2933 | 0.010 |
Why?
| Photic Stimulation | 1 | 1999 | 215 | 0.010 |
Why?
| Self Medication | 1 | 1998 | 8 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 1999 | 551 | 0.010 |
Why?
| National Institutes of Health (U.S.) | 1 | 1998 | 122 | 0.010 |
Why?
| Heterozygote | 1 | 1998 | 270 | 0.010 |
Why?
| Genetics, Population | 1 | 1999 | 212 | 0.010 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.010 |
Why?
| Dopamine | 1 | 2000 | 250 | 0.010 |
Why?
| Leukocytes, Mononuclear | 1 | 2000 | 514 | 0.010 |
Why?
| Genes | 1 | 1997 | 231 | 0.010 |
Why?
| Gene Expression | 1 | 2000 | 1506 | 0.010 |
Why?
| Mothers | 1 | 1999 | 728 | 0.010 |
Why?
| Child, Preschool | 1 | 1999 | 9755 | 0.000 |
Why?
|
|
Olincy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|